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Abstract 
Rationale, aims, and objectives: Inappropriate medication prescribing and use among older patients is a 
major patient safety and healthcare problem. To promote appropriate medication prescribing and use, 
comprehensive medication reviews (CMRs) by ward-based pharmacists, including follow-up telephone calls 
after hospital discharge, have been conducted in older patients in the context of a randomised controlled 
trial (RCT). One of the key actors in a CMR is the patient. To support the understanding of the effects of CMRs 
on patients’ health outcomes and improve clinical practice, knowledge about the patient perspective is 
needed. We therefore aimed to explore older patients’ experiences with, and views on, hospital-initiated 
CMRs and follow-up telephone calls by ward-based clinical pharmacists within an RCT. 
Methods: We conducted in-depth semi-structured interviews with fifteen patients (66-94 years) and carers 
from four hospitals in Sweden. Discussion topics included communication, information, decision-making, and 
effects on the patient. Interviews took place after discharge, were audio-recorded, transcribed verbatim, and 
thematically analysed using a framework approach. 
Results: In general, patients’ experiences and views were positive. Seven key themes were identified: 1) 
feeling of being taken care of and heterogenous health effects; 2) the pharmacist is competent; 3) despite 
the unclear role of pharmacists, their involvement is appreciated; 4) patients rely on healthcare professionals 
for decision-making; 5) importance of being informed, but receiving and retaining information is problematic; 
6) time, location and other factors influencing the effectiveness of CMRs; 7) generic substitution is a problem. 
Conclusions: Older patients generally have positive experiences with and views on CMRs and follow-up 
telephone calls. However, some factors, like the unclear role of the ward-based pharmacist and problems 
with receiving and retaining information, may negatively impact the effectiveness of these interventions. 
Future initiatives on hospital-initiated CMRs by clinical pharmacists should address these negative factors 
and utilize the positive views. 
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1 Introduction 
Inappropriate medication prescribing and use among older patients is a major patient safety and healthcare 
problem of global significance [1,2]. Up to 30% of all hospitalisations in older patients are medication-related 
and half of these are potentially preventable [3–5]. Even during hospitalisation and after discharge, many 
problems with the management of medication exist [6,7]. Performing comprehensive medication reviews 
(CMRs), a structured, critical examination of a patient's medications with the objective of reaching an 
agreement with the patient about treatment [8], in older patients can improve medication prescribing, 
optimise treatment benefit and minimise harm [9,10]. Clinical pharmacists have been introduced to multi-
professional teams at ward level to perform CMRs in hospitalised patients [10]. However, a lack of high 
quality evidence inhibits widespread implementation [11]. 
To fulfil the need for evidence, a cluster-randomised controlled trial, Medication Reviews Bridging Healthcare 
(MedBridge; www.clinicaltrials.gov: NCT02986425), is currently being performed in Swedish hospitals [12]. 
This trial aims to study the effects of CMRs, including follow-up after hospital discharge, on older patients' 
healthcare utilisation compared to usual care, i.e. no CMR. Intervention patients may receive a CMR in which 
a ward-based clinical pharmacist collaborates with the ward physician and the patient or carer (intervention 
1), or two follow-up telephone calls after hospital discharge in addition to a CMR (intervention 2), see Box 1. 
In both interventions, patient or carer involvement is an important element. 
 
Box 1 
Study interventions within the Medication Reviews Bridging Healthcare (MedBridge) trial [12] 
 
For a clinical trial in which the intervention comprises of multiple components and is dependent on the 
interaction with its context and behaviour of people, it is highly recommended to perform a process 
evaluation alongside the trial [13]. Qualitative approaches, such as interviews, focus groups and researcher 
observations are often used within process evaluations to provide detailed information about the 
implementation, mechanism of impact and the context of the different intervention components [13].  
One of the key actors in a CMR is the patient. Positive patient experience is associated with clinical 
effectiveness and patient safety [14]. Several quantitative tools and frameworks, such as the Picker Patient 
Experience Questionnaire, have been developed to measure patient experience [15]. Survey studies 
Study interventions within the MedBridge trial 
 
Intervention 1 ’Comprehensive medication review’ (CMR) 
A clinical pharmacist collaborates with the ward physician and the patient or carer to improve the appropriateness and 
effectiveness of the prescribed medications and their use, and to minimise the risk of medication-related problems. As soon as 
possible after admission, preferably within 24 h, a clinical pharmacist interviews the patient or carer interview to ensure the 
hospital list of medications is consistent with what medications the patient used at home, and to identify any medication-
related problems experienced by the patient. The clinical pharmacist then performs, in collaboration with the ward physician, a 
structured, critical examination of all the patient's medications in relation to the patient's conditions, based on information 
from the patient and the medical record. The objective is to reach an agreement between the pharmacist, physician and 
patient (or carer) about the continued appropriateness and effectiveness of the treatment, optimising the impact of 
medications and minimising the number of medication-related problems. Other issues, such as adherence, practical use of the 
medications (e.g. how to use an inhaler), dosage forms, adverse effects, interactions, and the patient's understanding of the 
condition and its treatment are considered when appropriate. The effects of medication changes are monitored during hospital 
stay and a final check of the patient's medication list and prescriptions is performed by the clinical pharmacist before 
discharge. If deemed necessary, additional contact between the physician, pharmacist and/or patient may take place during 
the admission to optimise medication treatment. 
 
Intervention 2 ’CMR with follow-up after discharge’ 
The same as intervention 1, with the addition of the pharmacist having the possibility to send an electronic medication referral 
to the patients’ general practitioner with recommendations on treatment monitoring or follow-up actions. Next to that, two 
follow-up telephone calls to the patient are made by the pharmacist 2-7 days and 1-2 months after discharge. The goal of these 
calls is to ensure that all information has been understood correctly and to find out if any problems, concerns or questions 
have arisen after hospital stay. The second phone call also aims to increase treatment adherence. If necessary, the clinical 
pharmacist provides counselling or takes any other additional actions. 
 
Control ‘Usual care’ 
Usual hospital care without a clinical pharmacist involved. 
 
   
 
   
 
generally report positive experience and satisfaction with CMRs [16–18], but a qualitative approach providing 
in-depth data is needed to get an understanding of the factors influencing these experiences in order to 
improve clinical practice [19].  
Although systematic reviews on qualitative studies investigating patient experience with different healthcare 
interventions exist [20,21], few qualitative studies have evaluated this regarding hospital-initiated CMRs, 
with or without follow-up calls, or similar services involving clinical pharmacists [22,23]. Garcia et al. [22] 
explored the experiences of coronary heart disease patients with pharmacist-led follow-up, including 
medication review, upon and after discharge from hospital in Norway. Patients expressed increased 
medication knowledge, and they felt safer, reassured and more involved in the management of their 
medication. The importance of physician-pharmacist collaboration was emphasized, but the role of 
pharmacists needed to be clarified in order for patients to know what to expect from them [22]. Similar 
findings were reported by Morecroft et al. [23]: older patients who had received hospital-based pharmacy 
services in the United Kingdom responded positively to the pharmacist’s availability, communication skills 
and information provided. However, limited knowledge of the pharmacists’ role was an impeding factor to 
constructive interaction between patients and pharmacists [23].  
The extent of transferability of these findings to other contexts, such as the Swedish hospital setting, is 
unclear. A detailed exploration of the patients’ perspective can support the understanding of the effects of 
hospital-initiated CMRs on patients’ health outcomes. We therefore present this nested qualitative study 
which aimed to explore older patients’ experiences with and views on hospital-initiated CMRs and follow-up 
telephone calls by ward-based clinical pharmacists within the MedBridge trial. 
2 Methods 
2.1 Study design and methodological approach  
A qualitative design with in-depth interviews was chosen to gain rich accounts of patient experiences and 
views. We have taken an interpretive approach as proposed by Ritchie and Lewis [24]. That is, we accepted 
that the reality exists independently of individual subjective understanding, but that it is only accessible to 
the researchers via the participants' interpretations. The Standards for reporting qualitative research (SRQR) 
[25] and Consolidated criteria for reporting qualitative research (COREQ) [26] were used to design and report 
the study.  
2.2 Setting 
This was a nested study within the MedBridge trial which was simultaneously being performed at four 
hospitals in three regions in Sweden: Uppsala University Hospital and the hospitals of Enköping, Västerås and 
Gävle. The hospitals were chosen because of the presence of wards where physicians and nurses are 
supported by a clinical pharmacist. The pharmacists had either completed a full-time one-year postgraduate 
programme in clinical pharmacy, in which the performance of CMRs played a central role, or they had 
completed undergraduate courses in clinical pharmacy and advanced pharmacotherapy. All pharmacists also 
had at least six months working experience with performing CMRs in a multi-professional team. Two wards 
per hospital were included. The wards differed in terms of medical specialty: geriatric, internal medicine, 
stroke, diabetes and nephrology. All patients aged 65 or older who were admitted to one of the wards were 
asked for informed consent to participate in the MedBridge trial [12]. Patients were excluded if they were in 
a palliative stage, had been subject to a medication review within the last 30 days, resided in another than 
the hospital’s region, or were admitted for only one day. During admission, patients received either one of 
the study interventions, as described in Box 1, or usual care without a clinical pharmacist involved at the 
ward. In total, 2640 patients (intervention 1: 922, intervention 2: 824, control: 894) were included in the 
MedBridge trial between February 2017 and November 2018. 
2.3 Sampling and recruitment 
The potential participants in this study were participants within the MedBridge trial who had received one of 
the two interventions and were taking care of their own medication management in the ambulant setting 
   
 
   
 
according to information from their medical record. Spouse or children responsible for the patient’s 
medication management (carers) were also considered potential participants. Patients were excluded if they 
could not specifically remember the contact with the clinical pharmacist during hospital stay.  
Purposive sampling was used to be able to identify themes which cut across a variety of patients [24]. In this 
approach, patients were sampled to ensure coverage across hospital wards and heterogeneity in terms of 
age, gender, intervention (1 or 2), clinical pharmacist involved, and the number (high or low) of medication-
related problems identified during the CMR. Those selected for interview were invited by telephone. The 
interview was preferably planned approximately one to four weeks after the patient’s hospital discharge to 
minimise problems with recalling the experience. For intervention 2 patients, the interview would be after 
the first follow-up telephone call, but before the second call. Recruitment and interviewing took place 
between September 2017 and April 2018. Participants provided written informed consent before the start 
of the interview. The researchers had a pharmacy (TK) and nursing (AK) background, were involved as study 
coordinators within the MedBridge trial, and had received training in qualitative research and interviewing 
prior to the study. The researchers had not been in contact with the participants prior to recruitment. Regular 
meetings were held between the researchers to discuss the recruitment process and ensure heterogeneity 
in the sample. 
Sampling was continued to the point of data saturation, defined as the point when no new additional data 
are found that develop a conceptual category or theme [27]. In our approach, 12 initial interviews were 
conducted and analysed, to identify key, recurring themes. After 12 interviews, three consecutive interviews 
with no new themes emerging were needed to reach the point of data saturation [27].  
2.4 Data generation and analysis 
A semi-structured discussion guide was used to guide the interviews (Appendix A in Supplementary material). 
The content of the discussion guide was based on the topics within the NHS Patient Experience Framework 
[28], the Picker Patient Experience Questionnaire [15], and the different intervention components within the 
MedBridge trial [12]: communication with the clinical pharmacist during hospital stay; decision-making 
process within the CMR; information provided during hospital admission; two telephone calls by the clinical 
pharmacist (for intervention 2 patients only); overall effect of the intervention on the patient. One researcher 
(TK) conducted all interviews at the participants’ hospital or residence. The participants were encouraged to 
be frank and speak freely. The interviewer asked follow-up questions rooted in the main topics to elaborate, 
clarify and confirm understanding. The interviews were audio-recorded, transcribed verbatim by one 
researcher (AK) and checked for transcribing accuracy by the same researcher who performed the interviews.  
Data analysis followed a framework approach as proposed by Ritchie and Spencer [24]. This approach 
involves familiarisation with the data, identifying themes, coding, constructing and filling the framework and 
interpretation. The two researchers discussed the coding framework being used and coded each interview 
independently using Open Code 4.03 [29], with consensus reached by discussion. Swedish was the primary 
language for the interviews, transcripts and coding. In the final interpretation phase, the sub-themes and key 
themes were translated into English. An audit trail with all research steps taken was kept throughout the 
recruitment, data generation and analysis process. 
2.5 Ethics and research trustworthiness 
The MedBridge trial received ethical approval from the Swedish Central Ethical Review Board (CEPN; 
registration number: Ö 21-2016) and additional ethical approval from the Regional Ethical Review Board in 
Uppsala for the patient interviews (EPN Uppsala; registration number: 2016-251-1). Research 
trustworthiness and rigour [30] were addressed in diverse ways throughout the research process (Table 1). 
 
Table 1 Strategies to ensure trustworthiness and rigour of the research process 
Credibility • Adopted appropriate, well recognised research methods [24,27] 
• Familiarity among the researchers with the study context (2.3. Sampling and recruitment) 
• Description of background and training of the researchers (2.3. Sampling and recruitment) 
• Triangulation via use of different types of participants (2.3. Sampling and recruitment) 
• Encouragement of participants to be frank and talk freely (2.4. Data generation and analysis) 
• Use of different researchers to independently analyse data (2.4. Data generation and analysis) 
• Scrutiny of the project by an experienced, external researcher (DS) 
   
 
   
 
• Examination of previous research to frame findings (4.1. Discussion) 
Transferability • Description of the context (2.2. Setting) and comprehensive description of the findings (3. Results) 
Dependability • Comprehensive methodological description to allow the study to be repeated (2. Methods) 
• Reflective appraisal of the study (4.1. Discussion) 
Confirmability • Description of the researchers’ ontological and epistemological position (2.1. Study design and 
methodological approach) 
• Recognition of limitations in study’s methods and their potential effects (4.1. Discussion) 
• Audit trail of the recruitment, data generation and analysis (2.4. Data generation and analysis) 
3 Results 
3.1 Patient characteristics 
In total, 15 interviews were conducted out of 36 patients or carers that were approached: seven patients 
(19%) did not answer the telephone, six (17%) did not remember the contact with the clinical pharmacist, six 
(17%) felt too sick to participate, one (3%) did not want to participate, and one carer (3%) was not available 
for interview. Table 2 summarizes the patient characteristics of the 15 participants. The age ranged from 66 
to 94 years and there was heterogeneity in the other characteristics as well. All eight hospital wards were 
represented, and nine clinical pharmacists had been involved in these patients’ CMRs. Twelve interviews 
were held with patients, two with both the patient and carer (in both cases the patients’ spouse) and one 
with the carer only (in this case the patient’s daughter). 
 
Table 2 Patient characteristics (n = 15) 
Age [mean years, (range)] 78 (66–94) 
Gender [n, (%)] 
Female 
Male 
 
7 (47) 
8 (53) 
Intervention [n, (%)] 
1. CMR  
2. CMR with follow-up after discharge 
 
6 (40) 
9* (60) 
Number of medication-related problems [median, (range)] 3 (0–8) 
Hospital ward specialty [n, (%)] 
Diabetes and/or nephrology  
Geriatric 
Internal medicine (acute and/or general) 
Stroke and/or neurology 
 
1 (7) 
2 (13) 
8 (53)  
4 (27) 
Interview with [n, (%)] 
Patient 
Patient and carer 
Carer 
 
12 (80) 
2 (13) 
1 (7) 
* One patient had already received two follow-up telephone calls when the interview was held. 
CMR, comprehensive medication review 
3.2 Key identified themes 
The seven key themes that emerged from the interviews are described below and listed in Table 3. The 
findings are supported by illustrative quotes with the interview number in parentheses (P1-14 for the 
patients; C6, C9 and C15 for the carers). 
 
Table 3 Key identified themes and sub-themes in order of appearance in the text 
Feeling of being taken care of and heterogenous health effects 
• Patients have a feeling of being taken care of 
• Understanding of the need of CMRs 
• It is good to perform a CMR, but the health effects are unknown 
• Heterogeneous effects on medication treatment 
• Positive or no effect on treatment adherence 
The pharmacist is competent* 
Despite the unclear role of pharmacists, their involvement is appreciated 
• Unclear role of the pharmacist 
• Limited understanding of the CMR process 
• Positive view on pharmacist involvement in healthcare 
   
 
   
 
• The pharmacist is available 
• It is the physician's responsibility 
Patients rely on healthcare professionals for decision-making 
• Limited role of patients in decision-making 
• Patients depend on healthcare professionals 
• Patients rather not take medication 
• Patients decide themselves 
Importance of being informed, but receiving and retaining information is problematic 
• It is important to be informed about medication 
• Good quality of information from the pharmacist 
• Recalling information is problematic 
• Patients receive a lot of other information at the hospital 
• Other information sources can be very helpful 
Time, location and other factors influencing the effectiveness of CMRs 
• Timing of the pharmacist contact can be essential 
• It is difficult to inform old and ill patients 
• The hospital ward is a suitable location 
• There is little time during discharge 
Generic substitution is a problem* 
* This key theme has no sub-themes 
CMR, comprehensive medication review 
3.2.1 Feeling of being taken care of and heterogenous health effects 
The contact with the clinical pharmacist, during both the CMRs and follow-up telephone calls, engendered 
“a feeling of being taken care of” (C6), being listened to and made patients and carers feel “safer” (P8). 
Patients were generally aware about potential problems with older patients being prescribed multiple 
medications. They acknowledged the need for CMRs and thought it was good that CMRs were being 
conducted. 
“Elderly get a lot of different medications and eventually it can become a complete mess. Then you have to 
clean the entire medication list and almost start over.” (P12)  
For most patients, it was however impossible to say whether the CMRs were effective in terms of health 
outcomes because they did not exactly know what happened during the CMR process (see paragraph 3.2.3.). 
Effects on health status, medication treatment or adherence to treatment, that were mentioned by patients 
were heterogeneous. Some could be “upset” (P2) because medication changes were made which they did 
not agree with, or they did not notice any difference. Other patients expressed “feeling much better” (P5), or 
having more control over their medications as a result of the CMR. 
3.2.2 The pharmacist is competent 
Experiences with and views on the pharmacists’ competence were only positive. Patients and carers assumed 
that the pharmacist was “knowledgeable” (P14) about medications, but they also experienced this by getting 
answers to questions or having discussions about their medications. Patients and carers felt that the 
pharmacist listened to them, and that the pharmacist was “accommodating” (C9), “calm and collected” (P4). 
“I could absolutely do that [ask questions about medications], because she was competent.” (C15) 
3.2.3 Despite the unclear role of pharmacists, their involvement is appreciated 
Patients and carers knew that the pharmacist checked “whether medications interacted with each other” 
(P11) and whether the patient received “the right medication” (C15). However, it was unclear what exactly 
the role of the clinical pharmacist at the ward was, and patients had little understanding about the CMR 
process.  
“I actually did not understand what she [the pharmacist] wanted.” (P10) 
Several patients were “surprised” (P12) or “confused” (P1) to meet a pharmacist at the ward, because they 
had “never experienced it before” (P5). They were generally unaware of medication-related problems 
identified by the pharmacist and discussions between the pharmacist and physician about their medication. 
   
 
   
 
This could lead to patients being “sceptical” (P4) and not knowing what to ask or expect from the pharmacist.  
“I sure did have questions, but […] I did not really know what the conversation was about.” (P7) 
Despite these issues, pharmacist-physician collaboration in healthcare was generally appreciated. 
 “You [the pharmacist] with your knowledge and the physicians with theirs can put your heads together and 
maybe come up with something better than the physician alone.” (P4) 
Most patients thought it was good that the pharmacist was available at the ward and had the time to go 
through the patients’ medications, because “physicians are very hard to get hold of” (P12). Some patients 
seemed more indifferent towards the pharmacist being involved. One patient expressed that it was “better 
to ask a physician” (P1) about medication, because it was the physician’s responsibility to prescribe 
medications.  
3.2.4 Patients rely on healthcare professionals for decision-making 
Patients had a limited role in decision-making during hospital stay: “You don’t have that much to say” (P5). 
They “totally trusted” (P14) healthcare professionals to “do the right thing” (P5), because patients had “no 
knowledge” (P14) about medication. Most patients just accepted the prescribed medication, even though 
they “actually didn’t want any medication at all” (P8). Some patients mentioned having discussed treatment 
options with the physician or pharmacist, and thought it would be better if patients were generally more 
involved.  
“I agreed to try it out as she [the pharmacist] suggested.” (P7) 
“The patient doesn’t get involved, but I think it would be very useful to understand why you get this 
medication.” (P13) 
Unlike during hospital stay, patients expressed that at home they decided what medication to take. 
“It is your own choice to refrain from certain medications and take the risk that something happens to you.” 
(P8) 
3.2.5 Importance of being informed, but receiving and retaining information is problematic 
Getting informed about medication was important. Patients expected to receive information about reasons 
for change and side effects, and to be able to ask questions regarding their medication. This expectation was 
generally met through the performance of the CMRs and follow-up phone calls, and the information was 
sufficient and understandable.  
“We, the patients, didn’t receive so much information before […] they just gave us our medication and you 
had to take it without questioning. But now […] you can question certain things and ask about it, which I think 
is very important.” (P5) 
However, information from hospital and primary care could sometimes be conflicting. 
“It is quite interesting that one [family] doctor thinks you should take those [medications] and then you’re 
here [at the hospital] and both a pharmacist and a doctor say ‘No, she will not have these medications, that 
is unnecessary’.” (P2) 
Problems with receiving and retaining information, as part of the CMRs, telephone calls and healthcare in 
general, were expressed in all interviews. It was difficult to remember who patients had spoken to during 
hospital stay and what kind of information they had received. Some just had “forgotten everything.” (P3) 
Several patients mentioned having had a good conversation with the pharmacist as part of the CMR, however 
recalling the content was problematic. This may have been affected by the number of contacts with different 
healthcare professionals at the hospital. 
“Yes, I thought it was a good conversation […] but unfortunately I cannot be more specific.” (P13) 
“There were so many doctors whom I talked to, so it’s hard to remember.” (C9) 
Therefore, it was essential for patients to receive written information upon hospital discharge. 
“I only received this medication list. They said they had taken away one [medication], but which one, or why, 
I don’t know. […] I don’t like that, I think they should explain why and what could happen. […] If I wouldn’t 
have received this list, I wouldn’t have known which medications I had.” (P13) 
   
 
   
 
3.2.6 Time, location and other factors influencing the effectiveness of CMRs 
Timing was an important aspect that could influence the perceived effectiveness of the CMRs. The 
conversation with the pharmacist could be too early, for example if patients were too ill, and the timing of 
the telephone calls could be unsuitable. 
“If you’re in hospital like this and just had a stroke, you’re not in the right condition [to talk].” (P7) 
“It was quite a short call, because me and my wife were just on our way out.” (P4) 
Patients’ age and health condition, e.g. “at my age or if you are a little demented” (P2), were mentioned as 
general factors influencing the performance of CMRs. The hospital ward was a suitable location for a CMR, 
but lack of time and haste during discharge from the ward were barriers to adequately inform patients. 
“We went home after lunch, but it was so messy, and we were in a hurry.” (P7) 
3.2.7 Generic substitution is a problem 
Generic substitution, the substitution of a prescribed branded medication by a lower-priced product 
containing the same active substance [31], was addressed as a serious problem for older patients with regard 
to their medication management and trust in the effects of their medication, resulting in a high risk for 
medication errors.  
“It is very disturbing for an older person that [...] when you go to the pharmacy to get your medication, the 
packages look different, the colours of the tablets are different, and the texts are very small. […] It is definitely 
a very high risk for a patient to make mistakes.” (P10) 
4 Discussion 
4.1 Discussion of key findings 
The patients’ experiences with and views on the CMRs and follow-up telephone calls were generally positive. 
This positivity was rooted in an understanding of the need for CMRs in older patients using multiple 
medications, the feeling of being taken care of and listened to, the competences and availability of the ward-
based pharmacist, and the provision of understandable and sufficient information to the patients about their 
medications. These results confirm findings from studies on CMRs by clinical pharmacists in a hospital setting 
[22,23]. Being recognized as an individual, trust in healthcare professionals, communication, information and 
support are key elements to ensure positive patient experience [28,32], which also seemed to be addressed 
by the CMRs and follow-up telephone calls in this study. 
Physician-pharmacist collaboration was valued, but just as within previous studies [22,23], the unclear or 
unknown role of the ward-based pharmacist was a barrier to constructive contacts between patients and 
pharmacists. Patients being surprised, sceptical or not knowing what to expect from the pharmacist, can lead 
to CMRs not achieving the desired impact on the patients’ management of their medications. Informing 
patients about the presence and role of the pharmacist may improve effectiveness. 
Shared decision-making is a key element of patient experience [28,32] and integrated in the CMR process 
[8,33,34]. However, patients expressed a limited role in decision-making during the CMRs within this study. 
Not all patients wanted to be involved as they relied on the healthcare professionals to provide them with 
the best care during hospital stay. This is also apparent in other studies where preferences for involvement 
in decision-making vary substantially, and up to half of the adult patients prefer to passively rely on 
healthcare professionals rather than playing a more active role [35,36]. Higher age and hospital setting, both 
present in our study, also decrease the willingness to be involved [37,38]. In this study, the low level of patient 
involvement seemed to be related to the lack of understanding about the CMR process. As patients or carers 
generally did not know whether treatment changes were a result of the CMR or usual care processes at the 
ward, it was also hard to know the effects of the CMRs. 
Despite limited involvement during hospital stay, it was important for patients and carers to be well-informed 
about their medication treatment upon discharge. However, problems with receiving and retaining 
information were expressed in all interviews. These problems are common in similar settings, even after 
receiving structured medication counselling upon discharge [39]. Discharge interventions aiming to increase 
patient empowerment are effective in reducing hospital readmissions [40]. Information upon or after 
   
 
   
 
discharge should therefore be tailored to the individual’s needs and provided in a way that patients can 
regain an active role in their medication management [32,41]. Although the MedBridge study protocol 
allowed for patient specific tailoring, the CMR did not necessarily involve patient contact with the pharmacist 
upon discharge and the pharmacists were not specifically trained in patient empowerment.  
Finally, generic substitution was repeatedly mentioned as a problem for medication management by older 
patients, leading to an increased risk for medication errors. Despite this being a well-known issue [31,42], it 
was not specifically addressed within the CMRs, as the ward-based pharmacists were not aware of which 
generic medications were dispensed at the community pharmacy. Closer collaboration between stakeholders 
on a national level may provide a solution to this problem.  
4.2 Limitations 
Despite multiple strategies to ensure trustworthiness and rigour of the findings, limitations exist. Patients 
were excluded for interview if they were not taking care of their own medication management at home, and 
one-sixth of all patients who were approached did not specifically remember the contact with the clinical 
pharmacist. This limits the credibility of our findings, but it also supports the key themes on the unclear role 
of pharmacist and problems with recalling information. The researcher who conducted the interviews had a 
background in pharmacy, which may have limited the honesty of the participants. To mitigate this limitation, 
confidentiality was emphasized and participants were encouraged to be frank and talk freely. Both 
researchers involved in the analysis were involved as study coordinators in the MedBridge trial, which may 
have led to coloured interpretations of the findings, consequently lowering confirmability. We therefore 
provided quotes from all participants to substantiate the identified themes. Finally, the transferability of the 
findings to other contexts may be limited, as we only included participants from four hospitals in Sweden. 
However, our results confirm findings from studies on similar initiatives within other countries and healthcare 
settings. 
4.3 Conclusion 
Older patients generally have positive experiences with and views on CMRs and follow-up telephone calls by 
ward-based clinical pharmacists. However, some factors, like the unclear role of the ward-based pharmacist 
and problems with receiving and retaining information, may negatively impact the effectiveness of these 
interventions.  
4.4 Practice implications 
This study supports the understanding of the effects of hospital-initiated CMRs and follow-up by clinical 
pharmacists on patients’ health outcomes within the MedBridge trial. Future initiatives on similar 
interventions should utilize older patients’ acknowledgement of the need for CMRs, trust in the competence 
of the pharmacist and appreciation of physician-pharmacist collaboration. These findings also raise questions 
for future research and practice, such as how to promote an understanding of the presence and role of the 
pharmacist at the ward, optimise patient communication and improve effectiveness of the CMRs. Instead of 
involving all hospitalized patients in decision-making, it seems essential to focus on enabling the patient to 
regain the role of active participant after discharge, understanding the results of the CMR process and 
changes to medication treatment. Future initiatives should also find out how to address problems with 
generic substitution to ensure optimal medication management by older patients. 
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